High Note Wealth’s GSK GSK Stock Holding History

High Note Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55	Hold	1	–	–	﹤0.01%	925
2025 Q4	$49	Hold	1	–	–	﹤0.01%	900
2025 Q3	$43	Sell	1 -6	-86%	-$234	﹤0.01%	859
2025 Q2	$269	Hold	7	–	–	﹤0.01%	795
2025 Q1	$271	Hold	7	–	–	﹤0.01%	781
2024 Q4	$237	Buy	+7	New	+$252	﹤0.01%	801

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

High Note Wealth's GSK Position: Q1 2026 in Review

High Note Wealth held its GSK (GSK) position steady in Q1 2026 at 1 share worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #925.

High Note Wealth first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. The position peaked at $271 in Q1 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

High Note Wealth held 1 share of GSK worth $55 as of Q1 2026.
High Note Wealth left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of High Note Wealth's portfolio in Q1 2026, its #925 holding.
High Note Wealth first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
High Note Wealth's GSK position peaked at $271 in Q1 2025.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.